CLEVELAND, Nov. 8, 2011 /PRNewswire/ -- DATATRAK International, Inc. (OTCQX: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced translation of DATATRAK ONE to Simplified Chinese for use in the Chinese market. Together, with CRO Connect Partner Tigermed, DATATRAK deployed its randomization and inventory supply management product, uIRT, in its first Chinese-only study.
“We are glad to work with DATATRAK and deploy its IRT product for the first time in local language for a clinical trial in China,” commented Wen Chen, Tigermed Vice President of Business Development. “This language enhancement is a demonstration of DATATRAK’s commitment to build its presence in the data management product category and improve the end-user experience in a fast growing emerging market. The offering is unique in a market where adopting an EDC product for a local trial is still not very common.”
“The conversion of DATATRAK ONE to Simplified Chinese has opened many doors for us in China,” stated Laurence P. Birch, DATATRAK’s Chairman of the Board and CEO. “From the signing of our CRO Connect Partnership in August to deploying our first trial in November, Tigermed has been instrumental in the growth of our China strategy and the promotion of DATATRAK ONE.”
About Tigermed Consulting Co.
Tigermed Consulting Co. is the leading Contract Research Organization in China providing full clinical development services from Phase I-IV and biometrics services with particular strength in oncology, virology and cardiology. Headquartered in Shanghai, Tigermed has successfully served over 280 clients both in and outside China since inception in 2004. Tigermed has a work force of approximately 600 staff and operates 39 field offices across China and a Phase I study unit in Changsha. More information about Tigermed is available at www.tigermed.net.
About DATATRAK International, Inc.
DATATRAK International is a worldwide technology and services company delivering eClinical solutions and related services for the clinical trials industry. DATATRAK built its multi-component, comprehensive solution on a single, unified platform and expanded this concept to include services delivery via DATATRAK’s Clinical and Consulting Services group. The Company delivers a complete portfolio of software products designed to accelerate the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities, faster and more efficiently than loosely integrated technologies. The DATATRAK ONE software solution, deployed worldwide through an ASP or Enterprise Transfer offering, supports Phase I - Phase IV drug and devices studies in multiple languages throughout the world. DATATRAK has offices located in Cleveland, Ohio; Bryan, Texas; and Cary (RTP), North Carolina. For more information, visit http://www.datatrak.net.
Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements are made based on management’s expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. For a list of certain of the factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company’s quarterly report filed with the OTCQX Market announcing its results for the three-month period ending June 30, 2011. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.
SOURCE DATATRAK International, Inc.
